Ludwig Kappos

Cituota

	Visi	Nuo 2019
Šaltiniai	127961	61627
h-rodyklė	150	96
i10-rodyklė	727	523

12000

6000

3000

9000

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024408 464 537 598 792 942 1500 1883 2116 2946 3873 4792 5792 6284 6739 7359 7429 7967 8855 9793 11281 10942 10457 10029

Viešas pasiekiamumas

Peržiūrėti viską

316 straipsnių

51 straipsnis

pasiekiami

nepasiekiami

Pagal finansavimo įpareigojimus

Bendraautoriai

Xavier MontalbanPatvirtintas el. paštas cem-cat.org
Jerry S Wolinsky, MDEmeritus Professor in Neurology, McGovern Medical School, UTHealth, The University of Texas HealthPatvirtintas el. paštas uth.tmc.edu
Frederik BarkhofVU University Medical CenterPatvirtintas el. paštas vumc.nl
Jens KuhleUniversity Hospital and University BaselPatvirtintas el. paštas usb.ch
Mark S. FreedmanUniversity of OttawaPatvirtintas el. paštas toh.ca
Gavin GiovannoniQueen Mary University of LondonPatvirtintas el. paštas giovannoni.net
Amit Bar-OrProfessor, University of PennsylvaniaPatvirtintas el. paštas pennmedicine.upenn.edu
Fred LublinIcahn School of Medicine at Mount SinaiPatvirtintas el. paštas mssm.edu
Jeffrey A CohenCleveland ClinicPatvirtintas el. paštas ccf.org
Stephen L. HauserUCSFPatvirtintas el. paštas ucsf.edu
Massimo FilippiSan Raffaele Scientific Institute, Vita-Salute San Raffaele UniversityPatvirtintas el. paštas hsr.it
Edan GillesUniversity HOSPITAL of Rennes (CHU) FrancePatvirtintas el. paštas chu-rennes.fr
Yvonne NaegelinUniversity Hospital BaselPatvirtintas el. paštas usb.ch
Nicola De StefanoProfessor of Neurology, Universtiy of Siena,Patvirtintas el. paštas unisi.it
Robert J FoxMellen Center for Multiple Sclerosis, Cleveland ClinicPatvirtintas el. paštas ccf.org
Alan J ThompsonProfessor of Clinical Neurology and Neurorehabilitation, University College LondonPatvirtintas el. paštas ucl.ac.uk
Shibeshih Mitiku BelachewBiogenPatvirtintas el. paštas biogen.com
BMJ UitdehaagHoogleraar Neurologie, Amsterdam UMCPatvirtintas el. paštas amsterdamumc.nl
Peter Calabresijohns hopkinsPatvirtintas el. paštas jhmi.edu
Maria Pia SormaniUniversity of GenoaPatvirtintas el. paštas unige.it

Stebėti

Ludwig Kappos

University of Basel and Research Center of Clinical Neuroimmunology and Neuroscience Basel (RC2NB)

Patvirtintas el. paštas uhbs.ch - Pagrindinis puslapis

Neurology Neuroimmunology Neuroimaging Clinical Trials Multiple Sclerosis


Pavadinimas Rūšiuoti pagal šaltinius Rūšiuoti pagal metus Rūšiuoti pagal pavadinimą	Cituota Cituota	Metai
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ... Annals of neurology 69 (2), 292-302, 2011	11197	2011
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018	7562	2018
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” CH Polman, SC Reingold, G Edan, M Filippi, HP Hartung, L Kappos, ... Annals of Neurology: Official Journal of the American Neurological …, 2005	6692	2005
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis CH Polman, PW O'Connor, E Havrdova, M Hutchinson, L Kappos, ... New England Journal of Medicine 354 (9), 899-910, 2006	4127	2006
Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014	4010	2014
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis L Kappos, EW Radue, P O'Connor, C Polman, R Hohlfeld, P Calabresi, ... New England Journal of Medicine 362 (5), 387-401, 2010	3302	2010
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ... New England Journal of Medicine 362 (5), 402-415, 2010	2861	2010
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012	2109	2012
Ocrelizumab versus placebo in primary progressive multiple sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... New england journal of medicine 376 (3), 209-220, 2017	2034	2017
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... New England Journal of Medicine 376 (3), 221-234, 2017	1969	2017
Neurofilaments as biomarkers in neurological disorders M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ... Nature Reviews Neurology 14 (10), 577-589, 2018	1700	2018
Oral fingolimod (FTY720) for relapsing multiple sclerosis L Kappos, J Antel, G Comi, X Montalban, P O'Connor, CH Polman, T Haas, ... New England Journal of Medicine 355 (11), 1124-1140, 2006	1335	2006
Randomized trial of oral teriflunomide for relapsing multiple sclerosis P O'Connor, JS Wolinsky, C Confavreux, G Comi, L Kappos, TP Olsson, ... New England Journal of Medicine 365 (14), 1293-1303, 2011	1298	2011
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ... The Lancet Neurology 15 (3), 292-303, 2016	1095	2016
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis G Disanto, C Barro, P Benkert, Y Naegelin, S Schädelin, A Giardiello, ... Annals of neurology 81 (6), 857-870, 2017	1086	2017
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018	1051	2018
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes L Kappos, CH Polman, MS Freedman, G Edan, HP Hartung, DH Miller, ... Neurology 67 (7), 1242-1249, 2006	1030	2006
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ... Nature genetics 41 (7), 776-782, 2009	1016	2009
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ... Multiple Sclerosis Journal 24 (2), 96-120, 2018	1000	2018
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ... The Lancet 378 (9805), 1779-1787, 2011	957	2011

Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.

Straipsniai 1–20

Šaltinių per metus

Dubliuoti šaltiniai

Sujungti šaltiniai

Pridėti bendraautoriusBendraautoriai

Stebėti

Cituota

Bendraautoriai